In addition to AICD increase in KRASMUT tumors, we found that tumor-specific CTLs from KRASMUT versus KRASWT tumors exhibited a significant increase in the expression of perforin and CD107a (Supplementary Fig. 2G), markers associated with cytotoxic activity. This evidence concerns the gene PRF1 and neoplasm.